Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Cash from Financing Activities (2020 - 2025)

LifeStance Health (LFST) has disclosed Cash from Financing Activities for 6 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 52.94% to -$1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$16.0 million, a 60.4% decrease, with the full-year FY2025 number at -$16.0 million, down 60.4% from a year prior.
  • Cash from Financing Activities was -$1.9 million for Q4 2025 at LifeStance Health, up from -$2.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $30.8 million in Q4 2023 to a low of -$15.2 million in Q4 2021.
  • A 5-year average of $4.2 million and a median of -$1.9 million in 2023 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: soared 183.49% in 2022, then plummeted 310.32% in 2025.
  • LifeStance Health's Cash from Financing Activities stood at -$15.2 million in 2021, then skyrocketed by 183.49% to $12.7 million in 2022, then surged by 143.53% to $30.8 million in 2023, then tumbled by 113.16% to -$4.1 million in 2024, then soared by 52.94% to -$1.9 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Cash from Financing Activities are -$1.9 million (Q4 2025), -$2.0 million (Q3 2025), and -$2.0 million (Q2 2025).